quinoxalines has been researched along with rifampin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sadrieh, N; Snyderwine, EG | 1 |
Bugaeva, OK; Makarovskaya, LN; Pavlovich, NV; Ryzhkova, VV; Zurabyan, VA | 1 |
López De Ceráin, A; Monge, A; Montoya, ME; Ortega, MA; Sainz, Y | 1 |
López de Ceráin, A; Martínez-Crespo, FJ; Monge, A; Montoya, ME; Ortega, MA; Sainz, Y | 1 |
Aldana, I; Ancizu, S; Benítez, D; Burguete, A; Cerecetto, H; González, M; Marín, A; Monge, A; Moreno, E; Pérez-Silanes, S; Solano, B; Torres, E; Villar, R | 1 |
5 other study(ies) available for quinoxalines and rifampin
Article | Year |
---|---|
Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Topics: Animals; Biotransformation; Cytochrome P-450 Enzyme System; Enzyme Induction; Erythrocebus patas; Female; Humans; Hydroxylation; Immunoblotting; Isoenzymes; Macaca fascicularis; Male; Microsomes, Liver; Mutagenicity Tests; Mutagens; Polychlorinated Dibenzodioxins; Quinolines; Quinoxalines; Rats; Rifampin; Species Specificity; Substrate Specificity | 1995 |
[In vitro influence of biologically active factors of microorganisms on antibiotic susceptibility of Yersinia pestis].
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Complement Activation; Doxycycline; Erythromycin; Furazolidone; Guinea Pigs; Humans; Microbial Sensitivity Tests; Penicillin G; Penicillins; Plague; Polymyxin B; Quinoxalines; Rifampin; Yersinia pestis | 1997 |
Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.
Topics: Antitubercular Agents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinoxalines; Rifampin; Spectrophotometry, Infrared; Structure-Activity Relationship | 1999 |
New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Cyclic N-Oxides; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quinoxalines; Rifampin | 1999 |
Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.
Topics: Animals; Antitubercular Agents; Magnetic Resonance Spectroscopy; Molecular Structure; Mycobacterium tuberculosis; Quinoxalines; Rifampin; Trypanosoma | 2009 |